Application of Dsb family genes

By regulating the Dsb family genes, especially the DsbA gene, the resistance of fermented bacteria to phages is improved, and the problem of phage infection during microbial fermentation is solved, ensuring the stability and economic benefits of the fermentation process.

CN117965641BActive Publication Date: 2024-11-15SHANGHAI JIAOTONG UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410280064.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-03-12
Publication Date
2024-11-15
Estimated Expiration
2044-03-12

AI Technical Summary

Technical Problem

During the microbial fermentation process, bacterial species are often infected by phages, resulting in fermentation failure or reduction in conversion rate. The existing prevention and control measures have failed to completely cure phage pollution, affecting production efficiency.

Method used

Using Dsb family genes, especially DsbA genes, to improve the resistance of fermented bacteria to phages by knocking out or regulating their function, inhibiting phage replication and lysis, the inhibitor of DsbA protein is developed to control phage release.

Benefits of technology

It effectively improves the resistance of fermented bacteria to phages, avoids interference with phage infection on the fermentation process, ensures the success rate and economic benefits of fermentation, and provides "ammunition" for phage therapy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117965641B_ABST
    Figure CN117965641B_ABST
Patent Text Reader

Abstract

The present invention relates to the determination and application of gene functions, and in particular to the application of Dsb family genes. Based on the transposon random insertion mutagenesis technology, the present invention has discovered functional genes directly related to phage replication, Dsb family genes, especially DsbA. The present invention found that after the DsbA gene was deleted, the fermentation strain showed resistance to phage infection, but the growth characteristics of the deleted strain did not change, suggesting that the DsbA gene has the potential to regulate phage replication, and can control phage infection in fermentation bacteria and improve fermentation efficiency. It was further determined through experiments that the DsbA protein relies on its own C49 and C52 two key amino acids mediated disulfide bond modification function, promotes the perforin Holin protein to use its own C17 to undergo oligomerization, regulates the Holin protein's ability to punch holes on the bacterial inner membrane, and then promotes bacterial lysis and progeny phage release.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the mining and application of gene functions, and in particular to the application of Dsb family genes. Background Art

[0002] Microbial fermentation refers to the process of using microorganisms to convert raw materials into various products needed by humans through specific metabolic pathways under suitable conditions. Fermentation engineering has a wide range of applications, involving many aspects such as food industry, pharmaceutical industry, energy industry, chemical industry, agriculture and environmental protection. The production level of microbial fermentation mainly depends on the genetic characteristics and culture conditions of the strain itself. Therefore, microbial industrial strains are the core of the biological fermentation industry, directly affecting the fermentation conversion efficiency, and are the key to the high-quality and high-efficiency development of the microbial fermentation industry.

[0003] However, in fermentation production, strains are often infected by bacteriophages, resulting in fermentation failure or reduced fermentation conversion rate, which directly affects the economic benefits of production enterprises. There are three main sources of phage contamination: first, the production strains carry phages; second, they are infected by phages during the fermentation process; third, a large number of phages exist in the production environment, which will spread everywhere with the flow of air, dust and people's movement, making it possible to sneak into all aspects of production. Over the years, production companies have attached great importance to the prevention and control of phages, and have taken a series of prevention and control measures to control phage contamination to a certain extent, and the degree of contamination has gradually decreased, but it has not yet achieved a "radical" effect. Therefore, it is an urgent problem to be solved in the microbial fermentation industry to explore the genes that affect phage infection of fermentation strains and use target genes to control phage infection. Summary of the invention

[0004] The purpose of the present invention is to provide the application of Dsb family genes (Escherichia coli disulfide oxidase genes), especially the function mining and application of Dsb family genes in regulating the anti-phage ability of fermentation bacteria, so as to solve the problems existing in the above-mentioned prior art. Using the DsbA gene described in the present invention as a target gene can effectively control phage infection.

[0005] To achieve the above object, the present invention provides the following solutions:

[0006] The present invention provides application of Dsb family genes in improving the anti-phage ability of fermentation bacteria. The Dsb family genes include DsbA, DsbB, DsbC or DsbD.

[0007] Preferably, the anti-phage ability of the fermentation bacteria is improved by knocking out the Dsb family genes of the fermentation bacteria.

[0008] Preferably, the fermentation bacteria include Escherichia coli, Lactococcus lactis, Lactobacillus lactis or Bacillus subtilis.

[0009] The present invention provides a Dsb family gene-deficient fermentation bacterium with anti-phage ability, which is obtained by knocking out the Dsb family gene of the basic strain using Red homologous recombination technology;

[0010] The Dsb family genes include DsbA, DsbB, DsbC or DsbD.

[0011] Preferably, the basic strains include Escherichia coli, Lactococcus lactis, Lactobacillus lactis or Bacillus subtilis

[0012] The present invention provides the application of the above-mentioned Dsb family gene-deficient fermentation bacteria in industrial fermentation.

[0013] The present invention provides application of Dsb family genes in promoting bacteriophage replication, wherein the Dsb family genes include DsbA, DsbB, DsbC or DsbD.

[0014] The present invention provides application of Dsb family genes in inhibiting phage lysis and fermentation bacteria. The Dsb family genes include DsbA, DsbB, DsbC or DsbD.

[0015] Preferably, the ability of bacteriophage to lyse fermentation bacteria is inhibited by knocking out the Dsb family genes of the fermentation bacteria.

[0016] Preferably, the basic strain includes Escherichia coli, Lactococcus lactis, Lactobacillus lactis or Bacillus subtilis.

[0017] The present invention discloses the following technical effects:

[0018] The present invention provides an application of Dsb family genes in improving the anti-phage ability of fermentation bacteria, wherein the Dsb family genes include DsbA, DsbB, DsbC or DsbD. Based on the transposon random insertion mutagenesis technology, the present invention discovers the functional gene directly related to phage replication - Dsb family genes, especially DsbA. In the specific implementation of the present invention, the Red homologous recombination technology is used to perform deletion analysis on the Dsb family genes, and it is found that after the Dsb family genes are deleted, the fermentation strain is resistant to phages, but the growth characteristics of the deleted strains are not changed, indicating that the Dsb family genes have the potential to regulate phage replication. It is further determined through experiments that the DsbA protein (Escherichia coli disulfide oxidase protein) depends on its own C49 and C52 two key amino acids mediated disulfide bond modification function, thereby affecting the process of phage SH2 lysing bacteria, and this effect occurs in the final process of phage lysis and release. DsbA protein promotes the oligomerization of Holin protein using its own C17, regulates its ability to make holes in the bacterial inner membrane, and then mediates bacterial lysis and the release of progeny phage. Based on these research results, DsbA protein can play an important application value in the treatment of fermentation engineering bacteria: that is, when controlling fermentation strains to avoid phage infection, the DsbA gene can be knocked out of the fermentation strain. The deletion strain does not affect the fermentation and transformation function of the strain, but the deletion strain will not be lysed due to phage infection, thereby successfully avoiding the lysis effect of phage on the fermentation strain, thereby ensuring the fermentation success rate and improving the economic benefits of the fermentation enterprise.

[0019] Moreover, since the phage perforin protein is the "timer" for phage to lyse bacteria, we can target DsbA protein and develop inhibitors of DsbA protein to limit perforin Holin oligomerization, avoid premature bacterial lysis, and enable phage to fully replicate in bacteria and produce a large number of phages, providing sufficient "ammunition" for phage therapy and improving the economic benefits of the phage industry. In addition, in the process of large-scale fermentation of engineered bacteria, in order to avoid fermentation failure, DsbA protein can also be used as a target for controlling phage contamination, which has research value. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0021] Figure 1is the PCR amplification result of the recombinant fragment, wherein A is the PCR amplification result of each segment of the recombinant fragment, 1 is DNAMarker DL5000, 2-4 are: F1 segment to F3 segment of RDsbA segment; B is the PCR amplification result of the recombinant fragment, 1 is DNAMarkerDL5000, 2 is RDsbA segment;

[0022] Figure 2 For the construction and identification of deletion strains, M is DNA Marker DL5000, 1 and 2 correspond to the PCR amplification products of the dsbA gene of the wild-type MG1655 (627 bp) and MG1655::△dsbA (no band), respectively; 3 and 4 correspond to the PCR amplification products of the wild-type MG1655 (2491 bp) and the resistance-eliminated MG1655::△dsbA (1889 bp), respectively.

[0023] Figure 3 Bacterial growth curves of wild-type strain, deletion strain infected with and not infected with phage;

[0024] Figure 4 The phage titer in the supernatant 2 hours after the wild-type strain, the deletion strain, and the deletion complemented strain were infected with phage;

[0025] Figure 5 The replication of phage SH2 depends on the active motif of DsbA protein. A is qRT-PCR verification of DsbA transcription level in different complemented strains. B is the replication ability of phage in different complemented strains. C and D are the motility and ring size of different complemented strains. The first row in C from left to right are MG1655, △dsbA and CDsbA, and the second row are CDsbAC49S, CDsbAC52S and CDsbAC49 SC52S, △dsbA is MG1655△DsbA, CDsbA is MG1655△DsbA:CDsbA, CDsbAC49S is MG1655△DsbA:CDsbAC49S, CDsbAC52S is MG1655△DsbA:CDsbAC52S, CDsbAC49SC52S is MG1655△DsbA:CDsbAC49SC52S;

[0026] Figure 6 Dsb family members do not affect the adsorption capacity of phage SH2, A is the plaque test, and B is the adsorption rate;

[0027] Figure 7 This is the one-step growth curve of bacteriophage SH2 on different deletion strains;

[0028] Figure 8Results of intracellular phage potassium ion determination (A) and phage DNA replication level detection (B) at different time points when phage infected wild-type strain and deletion strain;

[0029] Fig. 9 The morphology of intracellular phages was observed at different time points when the phages infected the wild-type strain and the deletion strain;

[0030] Fig.10 is the effect of DsbA gene on the lysis ability of phage SH2, A is the phage content in the supernatant after phage SH2 infected cells, B is the phage content in cells after phage SH2 infected cells, and C is the sum of intracellular and extracellular phage content; p<0.05 between the data of wild-type bacteria and deletion bacteria is considered statistically significant, ** represents p<0.01;

[0031] Fig.11 DsbA protein promotes the perforin protein Holin to play a bacterial splitting function. A is Western Blot analysis of the expression of Holin protein in wild-type and defective bacteria. B is Western Blot analysis of the expression of mutant SHolin protein. C is the bacterial growth curve. D is the colony count. E is the β-galactosidase activity detection. p<0.05 between the data of wild-type bacteria and defective bacteria is considered statistically significant. ** represents p<0.01

[0032] Fig.12 The effect of DsbA protein on perforin protein Holin oligomerization, A is Western Blot analysis of perforin protein oligomer formation, 1 is before BL21-Holin induction; 2 is 6h after BL21-Holin induction; 3 is before △DsbA-Holin induction; 4 is 6h after △DsbA-Holin induction; 5 is before BL21-SHolin induction; 6 is 6h after BL21-SHolin induction; B is the prediction of perforin transmembrane domain; C is perforin subcellular localization; perforin oligomer (D) and perforin mutant oligomer (E) structure prediction;

[0033] Fig.13 is the bacterial growth curve, ** represents the significant difference between the wild strain and the deletion strain, p<0.01. DETAILED DESCRIPTION

[0034] Example 1 Construction of deletion strains

[0035] 1. Obtaining recombinant fragments: Primers for knocking out the DsbA gene (accession number: 948353, https: / / www.ncbi.nlm.nih.gov / gene / ?term=) were designed based on the MG1655 genome sequence (NC_000913.3). The primer sequences are shown in SEQ ID NO.1-6 in Table 1. The specific steps are as follows:

[0036] After 25 μL PrimeSTAR Max Premix (2×), 2 μL upstream primer (10 pmol / μL), 2 μL downstream primer (10 pmol / μL), 2 μL template and 19 μL sterile water were mixed evenly, the F1, F2 and F3 segments of the fragments (targeting fragments) used for homologous recombination were amplified respectively, among which F1 and F3 used MG1655 bacterial solution as templates, and the F2 fragment containing chloramphenicol gene used pKD3 plasmid as template; the PCR amplification conditions were (98℃10s, 58℃30s, 72℃20s)×30 cycles, 72℃, 5min, and stored at 4℃. The PCR products were recovered according to the instructions of the FastPure Gel DNA Extraction Mini Kit of Novazon Biotech, and the F1, F2 and F3 segment products of the DsbA gene were obtained. The PCR amplification results of the three fragments are shown in the figure. Figure 1 As shown in A, the F1 segment product and the F3 segment product of the amplified recombinant fragment contain the upstream and downstream homology arms of the DsbA gene, and the size is 300 bp. Using the pKD3 plasmid as a template, the F2 segment product of the recombinant fragment, i.e., the chloramphenicol gene fragment, is amplified, and the size is 1016 bp.

[0037] In order to obtain the target fragment, the second round of PCR amplification reaction was carried out using the F1, F2 and F3 products of DsbA as templates and the primers F1 / R3 shown in SEQ ID NO.1-6 in Table 1 as upstream and downstream primers. The reaction system was 25 μL of PrimeSTARMax Premix (2×), 2 μL of upstream primer (10 pmol / μL), 2 μL of downstream primer (10 pmol / μL), template (2 μL each), and 15 μL of sterile water. The reaction procedure was the same as "1. Obtaining the recombinant fragment", and finally the RDsbA recombinant fragment containing the chloramphenicol gene was obtained. The PCR amplification results of the RDsbA recombinant fragment containing the chloramphenicol gene are shown in FIG. Figure 1 As shown in B, the recombinant fragment RDsbA containing the chloramphenicol gene is 1616 bp in size. The target fragment was recovered by gel cutting, and the concentration was measured and stored at -20°C.

[0038] 2. Preparation of electroporation competent cells: MG1655-pKD46 (construction method: take 50 ng plasmid pKD46, mix with 100 μL MG1655 competent cells, shake gently, place on ice for 30 minutes, heat shock in a 42°C water bath for 60-90 seconds, and quickly cool on ice for 3-5 minutes; add 1 mL LB liquid medium, pipette and mix well, and then culture in a shaker at 28°C and 220rpm for 1h. The above bacterial solution was shaken and centrifuged, 200μL of the medium was pipetted and mixed well, and 100μL was spread on an LB solid medium containing ampicillin resistance. The obtained colonies were further purified and identified, that is, the MG1655 strain containing plasmid pKD46) were streaked on an ampicillin-resistant LB solid medium and cultured at 28°C; and a single colony was picked up the next day in LB liquid medium (the concentration of ampicillin (Amp) in the medium was 100μg / mL) and cultured at 28°C with shaking until OD 600 When it is about 0.3-0.4, induce with arabinose inducer for 1.5h-2h, then centrifuge at 4℃, 6000r / min for 5min, discard the supernatant, resuspend the precipitate with 10% (volume percentage) glycerol, centrifuge again, repeat washing the precipitate 3 times, finally concentrate it by 5 times the volume, add the corresponding volume of 10% glycerol to resuspend the precipitate, take 100μL and distribute it into 1.5mL EP tubes, and put it at -80℃ for use.

[0039] 3. Construction of deletion strain: 100 μg of RDsbA recombinant fragment containing chloramphenicol gene was mixed with MG1655-pkD46 competent cell, and the mixture was gently transferred to an electroporation cup (1 mm); after ice bathing for 30 minutes, electric shock was performed, and the specific electroporation parameters of the electric shock were: V (voltage) = 190V, PC (resistance) = 200Ω, C (pulse) = 25 μF; preheated recovery LB medium (10 g sodium chloride, 10 g peptone, 5 g yeast extract, dissolved in 1 L pure water, high pressure standby) was quickly added to resuscitate the bacteria, and the recovery condition parameters were: 28°C, 200 r / min shaking culture for 1 hour; then centrifuged at 6000 r / min for 2 minutes, 1 mL of supernatant was discarded, 100 μL of supernatant was retained to resuspend the precipitate, and then all were coated on LB solid culture medium containing 20 μg / mL chloramphenicol, and placed in a 37°C incubator for inverted culture.

[0040] 4. Identification of deletion strains: Single colonies on LB solid medium containing 20 μg / mL chloramphenicol were picked up and cultured in 1 mL LB liquid medium (100 μg / mL Cm), and further PCR identification was performed using identification primers (SEQ ID NO.7-8), and MG1655 was used as a control. The PCR reaction system and conditions were the same as "1. Obtaining recombinant fragments", and the correct bands were cut and sent for sequencing.

[0041] Table 1 PCR primer sequences used to construct deletion strains

[0042] Primers Primer sequence (5'-3') SEQ ID NO. DsbA-F1 GCCTTTAACGGTCAGACTTTATTGAATCATCAGGG 1 DsbA-R1 AAGCAGCTCCAGCCTACACGATCTACTCTCCGATTAAT 2 DsbA-F2 TAATCGGAGAGAGTAGATCGTGTAGGCTGGAGCTGCTT 3 DsbA-R2 TATGTAATTTACATTGAACATATGAATATCCTCCTTAG 4 DsbA-F3 CTAAGGAGGATATTCATATGTTCAATGTAAATTACATAAA 5 DsbA-R3 GACAATGAACTACCATCACCATTAAAAGTAAAC 6 Identification of ΔDsbA-F GTCATTCGTAATGTTTTCCGGATGA 7 Identification of ΔDsbA-R TAATCTGATTAAATTTCGACTCGCT 8

[0043] Note: Underlined fragments represent homologous fragments.

[0044] The results are as follows Figure 2 As shown in 1 and 2, 1 is the size of the wild-type DsbA of 627bp, and 2 is the mutant strain amplified using the same primers. As shown in the figure, the corresponding band is no longer visible, which means the mutation is successful. It is named the deletion strain MG1655△DsbA.

[0045] 5. Elimination of resistance: First, prepare the transformation competent state. The main steps are: inoculate the correctly identified deletion strain MG1655△DsbA into LB liquid culture medium (the concentration of chloramphenicol (Cm) in the culture medium is 20 μg / mL), and culture at 37°C and 200r / min with shaking until the logarithmic growth phase; take 5mL and ice bath for 30min, centrifuge at 6000r / min at 4°C, carefully discard the supernatant, resuspend the precipitate with 0.1M CaCl2 and wash three times, finally add 1mL pre-cooled CaCl2 solution to mix the precipitate, and add 50% (volume percentage) of glycerol to a final concentration of 10% (volume percentage), and then place it at -80°C for use.

[0046] 6. Extract plasmid: inoculate pCP20 into LB liquid culture medium (the concentration of ampicillin (Amp) in the culture medium is 100 μg / mL), culture at 28°C, 200 rpm and shaking for 12 h, extract plasmid according to the instructions of Plasmid DNA Mini Kit, and store the obtained DNA in a -20°C refrigerator for later use.

[0047] 7. Transformation plasmid: Add 3 μL pCP20 plasmid to the competent bacteria prepared above, mix gently, place on ice for 30 minutes before heat shock at 42°C for 90 seconds, and place on ice for 2 minutes immediately after heat shock; add 500 μL LB medium, shake culture for 1 hour; centrifuge at 5000 r / min for 2 minutes, discard part of the supernatant, resuspend the precipitate and spread all on LB agar plate containing 100 μg / mL ampicillin, and place in a 28°C incubator for inverted culture for 16 hours. When a single colony grows, pick a single clone and streak it on LB solid culture medium. After culturing at 42°C for 12 hours, pick a single clone and place it in LB liquid culture medium, and identify it with identification primers (SEQ ID NO.7-8). The method is the same as "4. Identification of deletion strains", with wild-type MG1655 as the control, and the correct strain is stored in 25% glycerol and placed in a -80°C refrigerator for standby use.

[0048] The results are as follows Figure 2 As shown in Figures 3 and 4, after plasmid pCP20 was transferred into the deletion strain to eliminate resistance, the identification primers were used again to perform PCR amplification on each deletion strain. Figures 3 and 4 correspond to the PCR amplification products of wild-type MG1655 (2491 bp) and MG1655::△dsbA (1889 bp) with eliminated resistance, respectively. The results showed that the deletion strain MG1655△DsbA was successfully constructed.

[0049] Example 2 Determination of the growth curve of the deletion strain MG1655ΔDsbA

[0050] The bacterial solution containing wild-type MG1655 and the bacterial solution containing the deletion strain MG1655△DsbA were inoculated into LB liquid culture medium at a volume ratio of 1:100. At the same time, in order to detect whether the mutant strain can resist the replication of the phage, a phage infection group was set up, and phage SH2 (phage vB_EcoS_SH2, accession number: NC_047828.1) was added to different strains at MOI=1, and placed at 37°C, 200r / min shaking culture, and 100μL of bacterial solution was taken every 1h to 12h to measure its absorbance at 600nm, and the growth curve was drawn after statistics. The results are shown in Figure 3 As shown, the results showed that the growth characteristics of MG1655△DsbA and wild-type strain MG1655 were similar, and there was no significant difference in growth rate. However, in the presence of phage SH2, wild-type MG1655 began to be lysed by phage SH2 at 2 hours and was completely lysed by phage in a short time, while the deletion strain MG1655△DsbA could continue to grow.

[0051] Example 3 Determination of phage titers of deletion strains and wild-type strains

[0052] In order to detect the effect of different strains on phage proliferation, the double-layer plate method was used to determine the titer of phage in the supernatant after phage infection at different times. The specific steps are as follows:

[0053] Bacteria (deleted strain MG1655ΔDsbA, wild-type MG1655 and MG1655ΔDsbA:CDsbA (constructed in the same manner as in Example 4)) were cultured until the logarithmic growth phase (OD 600 =0.5-0.6), centrifuged at 5000r / min for 5min, discarded the supernatant, added LB liquid medium to resuspend the precipitate, and made the bacterial OD 600 Adjust to 1, add bacteriophage SH2 at MOI = 1, mix well and place in a 37°C incubator for 2 hours, collect the supernatant by filtering, dilute the filtrate with 1×SM buffer at different multiples, and determine the number of bacteriophages in the filtrate by the double-layer plate method. The results are as follows Figure 4As shown in the figure, after the deletion strain MG1655△DsbA and phage SH2 acted together for 2 hours, the number of progeny phages did not increase significantly, which was significantly different from the wild-type MG1655. However, the phage titer of the complement strain MG1655△DsbA:CDshA of MG1655△DsbA was restored to a level similar to that of the wild-type strain.

[0054] Example 4 Key sites of DsbA protein involved in phage replication

[0055] 1. Construction of expression vector

[0056] In order to verify the key sites involved in phage replication of DsbA protein (accession number: NP_418297.1), the two cysteines C49 and C52 in the active motif C49-P50-H51-C52 of DsbA protein that plays a role in introducing disulfide bonds were subjected to single point mutation and double mutation, respectively, and both were mutated to serine (S). Primers were designed using SnapGene software, and the primer sequences are shown in Table 2, where the bases introduced with mutations are marked in bold italics. The main steps are as follows: using MG1655 strain as template, the primer pair CDsbA-F / CDsbA-R was used to amplify the complemented fragment CDsbA; the primer pair CDsbA-F / DsbAS49-R and DsbAS49-F / CDsbA-R were used to amplify the fragments DsbAS49-A and DsbAS49-B; the primer pair CDsbA-F / DsbAS52-R and DsbAS52-F / CDsbA-R were used to amplify the fragments DsbAS52-A and DsbAS52-B; the primer pair CDsbA-F / DsbAS49S52-R and DsbAS49S52-F / CDsbA-R were used to amplify the fragments DsbAS49S52-A and DsbAS49S52-B. The primer sequences are shown in Table 2, and the PCR reaction system is shown in Table 3.

[0057] Table 2 Primer sequences used in expression vector construction

[0058]

[0059] Note: Underlined characters represent the homology arm primers of pBAD vector, and bold italics represent point mutations.

[0060] Table 3 PCR reaction system for amplifying each segmented gene

[0061] Total reaction volume 50μL PrimeSTARMaxPremix (2×) 25μL Upstream primer (10pmol / μL) 2μL Downstream primer (10pmol / μL) 2μL template 2μL Sterilized water 19μL

[0062] Overlap extension PCR was used to amplify the DsbA fragment with point mutation: the gel-recovered products DsbAS49-A and DsbAS49-B, DsbAS52-A and DsbAS52-B, DsbAS49S52-A and DsbAS49S52-B were used as templates, and CDsbA-F / CDsbA-R were used as upstream and downstream primers for amplification, respectively. The PCR reaction system (50 μL) included PrimeSTAR Max Premix (2×) 25 μL, upstream primer (10 pmol / μL) 2 μL, downstream primer (10 pmol / μL) 2 μL, template (2 μL each), and sterile water 17 μL; the PCR amplification conditions were the same as those in Table 4. The PCR products were gel-recovered and purified, and the obtained fragments were named CDsbA, CDsbAS49, CDsbAS52, and CDsbAS49S52, respectively.

[0063] The pBAD (DH5α) bacterial solution (kindly donated by Shanghai Veterinary Research Institute) was inoculated into 5 mL LB (the concentration of ampicillin (Amp) in the medium was 100 μg / mL) liquid medium at a volume ratio of 1:100, and cultured at 37°C for 12 hours. After the plasmid was extracted, double enzyme digestion was performed. The enzyme digestion system (50L): 10×Quick Cut Buffr 5μL, QuickCutHindⅢ1μL, QuickCutBamHI 1μL, DNA 20μL, sterile water 23μL, mixed evenly, placed in a 37°C water bath for 30 minutes, and analyzed by agarose gel electrophoresis. After confirming the results in an ultraviolet gel detector, the gel was cut and purified to recover the enzyme digestion products. The target fragments CDsbA, CDsbAS49, CDsbAS52, and CDsbAS49S52 were connected to the pBAD enzyme digestion recovery products using homologous recombination enzymes. The connection system is shown in Table 4. After mixing evenly, place it at 50℃ for 20min. After the reaction is completed, cool the reaction tube on ice, then add the reaction product to the melted Trans 5α competent cells for transformation, and place the prepared plate in a 37℃ incubator for inversion and culture for 12-15h. The next day, pick a single colony and use primers CDsbA-F / pBAD-R for PCR identification. The identification system (20μL): Green Taq Mix 10μL, upstream primer (10pmol / μL) 1μL, downstream primer (10pmol / μL) 1μL, template 1μL, sterile water 7μL; PCR reaction program: 95℃3min, (95℃15s; 58℃15s; 72℃2min)×30 cycles, 72℃5min, 4℃ storage. The PCR product was analyzed by 1% agarose gel electrophoresis, and the positive bacterial solution with correct identification was sent to Qingke Biotechnology Company for sequencing. The correctly sequenced strains pBAD-CDsbA, pBAD-CDsbAS49, pBAD-CDsbAS52, and pBAD-CDsbAS49S52 were transformed into MG1655△DsbA competent cells, and the correctly identified strains were named MG1655△DsbA:CDsbA, MG1655△DsbA:CDsbAC49S, MG1655△DsbA:CDsbAC52S, and MG1655△DsbA:CDsbAC49SC52S.

[0064] Table 4 Recombinant plasmid connection system

[0065] Components volume 2×HieffCloneEnzymePremix 10μL Expression vector 3μL Purpose fragment 5μL <![CDATA[ddH2O]]> 2μL

[0066] 2. qRT-PCR was performed on different complementation strains of MG1655△DsbA:CDsbA, MG1655△DsbA:CDsbAC49S, MG1655△DsbA:CDsbAC52S and MG1655△DsbA:CDsbAC49SC52S. The results showed that the transcription level of the DsbA gene was restored after complementation ( Figure 5 The results of phage titer determination are shown in Figure 5 As shown in B. The number of progeny phages in the wild-type strain increased by about 100 times relative to the amount added, while the number of progeny phages in MG1655△DsbA remained basically unchanged. However, after wild-type DsbA was complemented, the number of progeny phages in the supernatant was basically the same as that of wild-type MG1655, with no significant difference. However, when the DsbA active motif mutant plasmid was complemented, the strain's sensitivity to phages could not be restored, indicating that DsbA's participation in phage replication depends on the 49th and 52nd cysteines in the active motif C49-P50-H51-C52.

[0067] 3. Detection of bacterial motility and bacteriophage SH2 titer

[0068] MG1655, MG1655△DsbA, MG1655△DsbA:CDsbA, MG1655△DsbA:CDsbAC49S, MG1655△DsbA:CDsbAC52S, and MG1655△DsbA:CDsbAC49SC52S were cultured to the logarithmic growth phase (OD600=0.5-0.6), and 5 μL of each was dropped onto a soft agar LB plate (0.3% agar), and cultured in a 37°C incubator for 48 hours, and the diameter of the bacterial movement range was observed and measured. Figure 5 As shown in C and D in the figure, bacterial motility tests showed that the motility of MG1655△DsbA:CDsbAC49S, MG1655△DsbA:CDsbAC52S and MG1655△DsbA:CDsbAC49SC52S strains was similar to that of MG1655△DsbA, while MG1655△DsbA:CDsbA could compensate for the loss of motility due to the absence of DsbA, indicating that C49 and C52 play a key role in the disulfide bond modification function of DsbA.

[0069] Example 5 Effect of DsbB gene, DsbC gene or DsbD gene on phage replication

[0070] (1) Construction of deletion strains:

[0071] In order to explore the correlation between DsbB gene (accession number: NP_415703.3), DsbC gene (accession number: NP_417369.1) and DsbD gene (accession number: NP_418559.1) and phage replication, DsbB gene, DsbC gene and DsbD gene deletion strains were constructed with reference to the method in "Example 1". The primers used are shown in Table 5. The correctly constructed strains were named MG1655△DsbB, MG1655△DsbC and MG1655△DsbD, respectively.

[0072] Table 5 PCR primer sequences

[0073]

[0074]

[0075] Note: Underlined fragments represent homologous fragments.

[0076] (2) Plaque assay:

[0077] Wild-type MG1655, MG1655△DsbA, MG1655△DsbB, MG1655△DsbC and MG1655△DsbD were cultured to the logarithmic growth phase (OD 600 =0.5-0.6), take 100 μL and mix with the upper culture medium, slowly pour it on the LB solid culture medium to make a double-layer plate, and after solidification, take 5 μL of phage suspension with different dilution multiples and spot it on the plate, culture it at 37°C until the plaque morphology is uniform, and finally count the maximum lysis dilution multiple of the phage on different strains. The plaque test showed that phage SH2 can form clear plaques on MG1655△DsbA, MG1655△DsbB, MG1655△DsbC and MG1655△DsbD, but compared with the wild-type strain MG1655, the phage titer in MG1655△DsbA, MG1655△DsbB, MG1655△DsbC and MG1655△DsbD is significantly reduced (3). Figure 6 A)

[0078] (3) Determination of one-step growth curve:

[0079] Strains MG1655, MG1655△DsbA, MG1655△DsbB, MG1655△DsbC and MG1655△DsbD were cultured to the logarithmic phase (OD 600=0.5-0.6), mixed with phage SH2 (phage to bacteria infection ratio = 0.1), cultured at 37℃160rpm, sampled 100μL every 10min (until 150min), centrifuged at 4℃12000rpm for 2min, filtered with 0.22μm filter, and the filtrate was diluted in multiples to determine the phage titer at different time points. With the infection time as the horizontal axis and the phage titer as the vertical axis, the one-step growth curve of phage SH2 in different strains was drawn. The results are shown in Figure 7 As shown: The incubation period of bacteriophage SH2 in wild-type MG1655 is about 20 minutes, and its burst period is 20-50 minutes, with a burst volume of about 101PFU / cell. When the DsbA gene, dsbB gene, dsbC gene and dsbD gene are missing, the replication of the phage is significantly inhibited, and the burst volume is only 1.9PFU / cell, 2.2PFU / cell, 0.3PFU / cell and 0.33PFU / cell. The above results show that each member of the Dsb family plays an important role in the process of phage replication.

[0080] (4) Phage adsorption test:

[0081] In order to verify whether Dsb family members are involved in the adsorption process of phages, the cells were cultured to the logarithmic phase (OD 600 =0.5-0.6) of MG1655, MG1655△DsbA, MG1655△DsbB, MG1655△DsbC and MG1655△DsbD, add bacteriophage SH2 to make the final MOI=1; place the mixed solution in a 37°C shaker for 10 minutes, then take 1 mL respectively, centrifuge at 12000r / min for 1 minute, filter with a 0.22μm filter to remove bacterial impurities, and collect the supernatant. The double-layer plate method was used to determine the residual phage content in the supernatant, and the phage adsorption efficiency was calculated according to the formula of phage adsorption rate=(initial amount of phage-content in the supernatant after adsorption) / initial amount of phage. Compared with the wild-type MG1655, there was no significant difference in the adsorption capacity of MG1655△DsbA, MG1655△DsbB, MG1655△DsbC and MG1655△DsbD to phage SH2. After interacting with phage SH2 for 10 minutes, more than 90% of the phages could be irreversibly adsorbed to the strain ( Figure 6 B).

[0082] The results of phage adsorption test and plaque test showed that the deletion of DsbA gene, DsbB gene, DsbC gene and DsbD gene did not destroy the phage receptors on the bacterial surface and did not affect the adsorption process of phage SH2.

[0083] (5) Determination of potassium ion efflux:

[0084] MG1655, MG1655△DsbA, MG1655△DsbB, MG1655△DsbC and MG1655△DsbD were cultured to the logarithmic phase (OD 600 =0.5-0.6) for low-speed centrifugation, carefully discard the supernatant, resuspend the precipitate with 1×SM buffer and wash twice, and finally resuspend the precipitate with an equal volume of 1×SM buffer. Further, add purified phage SH2 to MG1655, MG1655△DsbA, MG1655△DsbB, MG1655△DsbC and MG1655△DsbD respectively, so that the final MOI=50, and set up blank controls respectively. The samples continue to be cultured at 37°C with shaking, and 3mL of the mixed solution is centrifuged at 0min, 3min, 5min and 10min respectively, 12000r / min, centrifuged for 2min, and then filtered with a 0.22μm filter, and 2.5mL of each sample is stored at 4°C.

[0085] After the sample was diluted to 5 mL with ultrapure water, 1 mL of nitric acid was added and placed at 120°C for nitration reaction. After 1 hour of reaction, the potassium ion content in each sample was detected by inductively coupled plasma emission spectrometry. The potassium ion content at each time point in the phage-infected group minus the potassium ion content at the corresponding time point in the group without phage addition is the potassium ion efflux content Ktn caused by phage DNA injection. Taking the T0 (0min) time point as the benchmark, (Ktn at different time points - Ktn at T0 time point) / Ktn at T0 time point is the increase in potassium ion emission at that time point. The results are as follows Figure 8 A in the figure shows that after adding phage SH2, the potassium ion content in the supernatant of MG1655△DsbA and wild-type MG1655 has a similar growth trend, with an explosive growth in the first 3 minutes of phage infection and stabilization after 5 minutes, indicating that the large amount of phage DNA injected in the first 5 minutes caused changes in the bacterial membrane ion channel. When DsbB is missing, although the amount of phage DNA injected is low in the early stage of infection, the amount of phage DNA injected is consistent with MG1655△DsbA as the infection time increases. However, when DsbC and DsbD are missing, there is no obvious change in the potassium ion content in the supernatant, and the growth rate is only 21%-24%, which is nearly 3 times the potassium ion growth rate of 68% in wild-type MG1655, indicating that the loss of DsbC and DsbD affects the injection of phage SH2 DNA.

[0086] (6) Detection of bacteriophage DNA replication level:

[0087] MG1655, MG1655△DsbA, MG1655△DsbB, MG1655△DsbC and MG1655△DsbD were inoculated into LB liquid medium and cultured to the logarithmic phase (OD 600 =0.5-0.6), add bacteriophage SH2 at MOI=1, incubate at 37°C with shaking, take 1 mL of sample at 5 min, 10 min, 15 min and 25 min, respectively, and extract total DNA with reference to "3. qRT-PCR" in Example 2. Use bacteriophage SH2 tail-fiber protein as template, design primers (Table 6) for qRT-PCR analysis.

[0088] Table 6 qRT-PCR primer sequences

[0089] Primers Primer sequence (5'-3') SEQ ID NO. qTF-F CCCTGAAGCCATAAACCTGA 46 qTF-R CGCTGATAGTGGTGCTGAAA 47 tmRNA-F GGCAAGCGAATGTAAAGACTGA 48 tmRNA-R CCGCGTCCGAAATTCCTA 49

[0090] The phage tail-fiber replication efficiency was detected by qRT-PCR. Figure 8 As shown in B, 40 minutes after phage SH2 infection, the phage tail-fiber protein increased by more than 100 times in MG1655, MG1655△DsbA and MG1655△DsbB bacteria, while the phage DNA did not increase significantly in MG1655△DsbC and MG1655△DsbD bacteria.

[0091] The results of the determination of potassium ion efflux and the detection of phage DNA replication level showed that DsbA protein and DsbB protein did not participate in the injection and replication of phage SH2 DNA, while DsbC protein and DsbD protein of the same family belonging to the reduction pathway were involved in the injection and replication of phage SH2 DNA.

[0092] Example 6 Effect of DsbA gene on phage release

[0093] (1) Preparation of ultrathin section samples: In order to further verify that DsbA affects the replication of phages, MG1655 and MG1655△DsbA were cultured to the logarithmic phase, and purified phage SH2 was added at an MOI of 1, and cultured at 37°C with shaking. After 10 min, 25 min, and 35 min, 1 mL of sample was centrifuged at 12000 r / min, and the supernatant was discarded. The precipitate was immersed in 2.5% (vol / vol) glutaraldehyde solution and fixed at room temperature for 6 h and then placed in a 4°C refrigerator. The liquid sample was encapsulated in an agar gel tube and post-stained with 2% (wt / vol) osmium tetroxide and 0.04% (wt / vol) ruthenium red. After dehydration in graded ethanol (50, 70, and 90% [vol / vol] ethanol), the samples were replaced in ethanol-acetone mixture 1 (90% ethanol: 90% acetone = 1:1, volume ratio), 90% acetone, and 100% acetone, and the samples were embedded in resin (acetone: resin was mixed at 1:1 and 1:2, respectively). After the resin was polymerized (70°C, 48h), the sections were sliced, and then the sections were stained with uranyl acetate and lead citrate aqueous solution, and the phage morphology was observed by transmission electron microscopy (Talos L120C G2, 120kV). The results are shown in Figure 2. Fig. 9 As shown, the results show that phage particles with an icosahedral structure can be observed in the cell, with a diameter of about 50nm, and a high electron density inside the head, indicating that the phage head is full of DNA, and as time goes on, the content of intracellular phage particles continues to increase, indicating that phage SH2 can be normally assembled in the cell, and in the late stage of phage infection, the structure of wild-type MG1655 is destroyed, resulting in the fragmentation of the bacterial membrane, and phage particles can be seen around. After the loss of the DsbA gene, in the late stage of phage infection, most bacteria still maintain a relatively complete morphology. The above results show that the DsbA gene does not affect the assembly of phage SH2.

[0094] (2) Detection of intracellular phage content:

[0095] Strains MG1655, MG1655ΔDsbA and MG1655ΔDsbA:CDsbA were cultured to the logarithmic phase (OD 600=0.5-0.6), after adjusting the bacterial concentration to be consistent, add phage according to MOI=1, and take 1mL of the mixed solution at 10min, 20min and 40min of infection according to the one-step growth curve of the phage, centrifuge at 12000r / min for 1min, filter with a filter, collect the supernatant and set aside; wash the precipitate 1-2 times with an appropriate amount of 1×PBS, and finally resuspend the precipitate with 500μL PBS, and perform ultrasonic disruption to release the intracellular progeny phage. The disruption parameters are: ultrasonic for 6s, stop for 9s, and ultrasonic for 1min. The sample after ultrasonic disruption is filtered again with a filter, and finally the double-layer plate method is used to detect the phage titer in each supernatant before and after ultrasonication. The results are as follows Fig.10 The results showed that as the phage infection time increased, the phage concentration in the supernatant of wild-type MG1655 continued to increase, and increased by nearly 100 times at 40 minutes. After the DsbA gene was deleted, the phage concentration in the supernatant remained basically unchanged. After the DsbA gene was supplemented, the phage concentration in the supernatant was basically the same as that of the wild type ( Fig.10 After ultrasonic disruption, it was found that the intracellular phage content of the three was basically the same, and all increased with the increase of phage infection time. In the late stage, the intracellular phage content of wild-type MG1655 and MG1655△DsbA:CDsbA was lower than that of MG1655△DsbA, and the corresponding extracellular phage content was significantly higher than that of MG1655△DsbA. This may be because in the late stage of infection, the bacteria of wild-type MG1655 and MG1655△DsbA:CDsbA were lysed in large quantities, and the progeny phages were released into the extracellular space ( Fig.10 B in the figure). The extracellular and intracellular phage contents were counted and it was found that even after the loss of DsbA, the total amount of phage remained the same as that of the wild strain ( Fig.10 C).

[0096] From the above results, it can be seen that the deletion of DsbA gene will not affect the early stage of phage replication, but will affect the phage lysis process.

[0097] Example 7 DsbA protein promotes the oligomerization of Holin protein and thus affects phage release

[0098] (1) Construction of prokaryotic expression vectors of bacteriophage perforin Holin protein and lysin protein:

[0099] The bacteriophage SH2 genome was used as a template and the primers used were as shown in Table 7. The pET-28a vector or pcold-TF was connected. Since it was found during the experiment that the pET-28a vector connected to the exogenous gene could not be expressed in the strain lacking the DsbA gene, the T7 promoter of the vector was replaced by the CSPA promoter (CCGATTAATCATAAATATGAAAAATAATTGTTGCATCACCCGCCAATGCGTGGCTTAATGCACATCA, SEQ ID NO.50). The method was as follows: the primer pair 28a-CspA-F (CGGGTGATGCAACAATTATTTTTCATATTTATGATTAATCGGATTT CGCGGGATCGAGA, SEQ ID NO.51) and 28a-CspA-R (ATTGTTGCATCACCCGCCAATGCGTGGCTTAATGCACATC AGGAATTGTGAGCGGATAA, SEQ ID NO.52) The pET-28a vector was transformed and then digested with enzymes. The digestion system (50 μL) was as follows: 10×QuickCutBuffr 5 μL, QuickCutHindⅢ1 μL, QuickCutBamHI 1 μL, DNA 20 μL, sterile water 23 μL. After mixing evenly, the mixture was placed in a 37°C water bath for 30 min. The digestion results were analyzed by 1% agarose gel electrophoresis and connected with the target fragment. The primer pairs 28a-Holin-F / 28a-SHolin-R and 28a-SHolin-F / 28a-Holin-R were amplified. The 17th cysteine ​​(TGC) of the Holin protein was missense mutated to serine (TCC). The correctly identified plasmids were transformed or co-transformed into BL21 (DE3) and BL21△DsbA competent cells to obtain eight expression strains, which were:

[0100] BL21-28a-Holin (Holin protein was linked to the pET28a vector and expressed in strain BL21);

[0101] BL21-28a-SHolin (Holin17 cysteine ​​mutant protein was connected to the pET28a vector and expressed in the strain BL21), the amino acid sequence of Holin17 cysteine ​​mutant protein is shown in SEQ ID NO.59, specifically: VGAATGQLYIAGATFISFLLFGAWGAYWKYRDSKAIQEALNDGDLNKALKIRGR, wherein the bold part is the original sequence C (position 17) mutated to S;

[0102] BL21ΔDsbA-28a-Holin (Holin protein was linked to the pET28a vector and expressed in strain BL21ΔDsbA);

[0103] BL21ΔDsbA-28a-SHolin (Holin17 cysteine ​​mutant protein was connected to the pET28a vector and expressed in the strain BL2ΔDsbA 1), the amino acid sequence of Holin17 cysteine ​​mutant protein is shown in SEQ ID NO.59;

[0104] BL21-pcold-Lysin (Lysin protein linked to pCold-TF vector and expressed in strain BL21);

[0105] BL21ΔDsbA-pcold-Lysin (Lysin protein was linked to the pCold-TF vector and expressed in strain BL21ΔDsbA);

[0106] BL21-Holin-Lysin (Holin protein was connected to pET28a vector, Lysin protein was connected to pCold-TF vector, and co-expressed in BL21 strain;

[0107] BL21△DsbA-Holin-Lysin (Holin protein was connected to the pET28a vector, Lysin protein was connected to the pCold-TF vector, and co-expressed in the BL21△DsbA strain).

[0108] Table 7 Primer sequences used in expression vector construction

[0109]

[0110] Note: Underlined fragments represent homologous fragments, and bold italic bases represent missense mutations.

[0111] (2) Western Blot analysis:

[0112] BL21-28a-Holin, BL21△DsbA-28a-Holin, BL21-28a-SHolin, BL21△DsbA-28a-Sholin, BL21-pET-28a and BL21△DsbApET-28a were inoculated into 5 mL of liquid LB medium (K + The concentration of 50 μg / mL) was incubated at 37°C with shaking until the bacterial OD 600=0.3-0.4, add IPTG to a final concentration of 1mmol / L for induction, and take 1mL of sample before induction as a control. Take 1mL of sample at 0h, 3h and 6h of induction, centrifuge at 4℃, 12000r / min for 2min; discard the supernatant, take 1mL of 1×PBS to wash the precipitate; add 500μLPBS to resuspend the precipitate, and perform ultrasonic disruption; centrifuge after disruption, take appropriate supernatant and mix with 5×SDS-PAGE loading buffer, boil in boiling water for 10min, and store at -20℃ for later use, then perform SDS-PAGE analysis, followed by Coomassie Brilliant Blue staining and Western Blot analysis. Western Blot results show that protein expression can be observed after IPTG induction for 0h, 3h and 6h ( Fig.11 A and B in ).

[0113] (3) Effect of Holin on bacterial growth:

[0114] BL21-28a-Holin, BL21△DsbA-28a-Holin, BL21-28a-Sholin and BL21△DsbA-28a-SHolin were shaken and cultured to OD 600 =0.3-0.4, add IPTG to a final concentration of 1mmol / L, induce at 28℃, 200r / min, and measure OD every 1h 600 , and draw a growth curve; BL21-pET-28a (purchased from Beijing Quanshijin Biotechnology Co., Ltd.) and BL21△DsbApET-28a (construction method: refer to steps 2-7 in Example 1) were used as blank controls. At the same time, appropriate amounts of bacterial liquid were taken at 2h, 4h, 6h and 8h for multiple dilutions and plated on LB plates (the culture medium has K + The content of Holin protein was 50 μg / mL) and the colonies were counted after overnight culture at 37°C. By detecting the growth of bacteria, it was found that with the expression of Holin protein, the growth of bacteria was inhibited, while the deletion strain could grow stably ( Fig.11 Correspondingly, at 6h and 8h, the expression of perforin caused the number of wild-type bacterial colonies to decrease by about ten times and was significantly different from the number of colonies of the deletion strain ( Fig.11 D).

[0115] (4) Determination of β-galactosidase activity:

[0116] The BL21-28a-Holin, BL21△DsbA-28a-Holin, BL21-28a-Sholin and BL21△DsbA-28a-SHolin strains were cultured at OD 600=0.3-0.4, IPTG was added and induced at 28°C, 200 r / min for 8 h, and samples were collected. BL21-pET-28a (purchased from Beijing Quanshijin Biotechnology Co., Ltd.) and BL21△DsbApET-28a (construction method: refer to steps 2-7 in Example 1) were used as blank controls. BL21(DE3) and BL21△DsbA were cultured to the logarithmic growth phase (OD 600 =0.4-0.5), and collected samples after infecting phage SH2 at MOI=1 for 30 minutes. After centrifuging the collected samples at 12000r / min for 1 minute, 500μL of supernatant was taken and mixed with 100μL 20mM ortho-Nitrophenyl-β-galactoside (ONPG), and after acting in a 45℃ water bath for 30 minutes, 600μL Na2CO3 (0.5mM) was added to terminate the reaction. The absorbance of the mixed solution at OD420 nm was detected by an ELISA instrument. After 30 minutes of phage infection of wild-type bacteria, the β-galactosidase activity in the supernatant was significantly higher than that of the strain lacking DsbA, indicating that the infection of the phage caused damage to the bacterial inner membrane, and the lack of DsbA caused the phage to be unable to destroy the integrity of the bacterial inner membrane. At the same time, the β-galactosidase activity in the supernatant of the wild-type bacteria after 8 h of expression of Holin protein was significantly higher than that of the deletion strain, indicating that the loss of DsbA inhibited the destruction of the bacterial inner membrane by Holin protein ( Fig.11 E).

[0117] From the above, we can see that when the C17 of Holin protein is replaced, the bacterial growth curve ( Fig.11 C in), colony count ( Fig.11 D) and β-galactosidase activity test results ( Fig.11 E) in the figure shows that there is no significant difference between the deletion type and the wild-type bacteria, and there is no significant difference with the blank control group BL21-pET-28a, indicating that the cysteine ​​at position 17 is extremely important for the bacteriolysis function of Holin protein.

[0118] (5) Non-denaturing polyacrylamide gel electrophoresis analysis:

[0119] BL21-Holin, BL21△DsbA-Holin and BL21-SHolin were inoculated into 5 mL of liquid LB medium (K + The concentration was 50 μg / mL) and the OD 600= 0.3-0.4, IPTG was added, and the samples were collected after induction at 28°C, 200r / min for 6h, and non-denaturing non-reducing loading buffer was added and frozen at -20°C for later use. The preparation system for non-denaturing polyacrylamide gel electrophoresis analysis is shown in Tables 8 and 9, and the subsequent method is the same as the aforementioned Western Blot analysis, with Escherichia coli DnaK protein as the internal reference protein.

[0120] Table 8 10% separation gel system

[0121] Separation gel composition Volume / mL 30% (29:1) acrylamide solution 3.3 1.5M Tris-HCl, pH 8.8 2.5 Distilled water 4.1 10% APS 0.1 TEMED 0.004

[0122] Table 95% concentrated gel system

[0123] Separation gel composition Volume / mL 30% (29:1) acrylamide solution 0.33 0.5M Tris-HCl, pH 6.8 0.5 Distilled water 1.15 10% APS 0.02 TEMED 0.002

[0124] In order to explore the effect of DsbA on the bacteriolysis function of perforin Holin, the expression of Holin in wild-type BL21 and BL21△DsbA-deficient strains was analyzed by non-denaturing polyacrylamide gel electrophoresis, because perforin often exists in the form of "raft"-like oligomers when it functions and makes holes in the cell membrane. The results are shown in Figure 2. Fig.12 As shown in A, after 6 hours of induction, Holin can form oligomers in wild-type bacteria, but when DsbA is missing, Holin protein exists in an immature form. Similarly, when C17 of Holin protein is mutated, mature oligomers cannot be formed.

[0125] (7) Analysis of the structure and localization of perforin:

[0126] The transmembrane region of Holin protein was analyzed with the help of TMHMM 2.0 software (https: / / services.healthtech.dtu.dk / service.php?TMHMM-2.0). PSORT Prediction (http: / / psort1.hgc.jp / form.html) was used to predict the subcellular localization of Holin protein. AlphaFold2 was used to predict the structure of Holin protein. The transmembrane domain of Holin protein was predicted using TMHMM 2.0 software. It was found that the amino acids 1-4 at the N-terminus of perforin Holin protein were located on the outside of the cell membrane, the amino acids 28-54 were located on the inside of the cell membrane, and the amino acids 5-27 formed a transmembrane structure, which belongs to class III perforin ( Fig.12 B), which is consistent with the localization of Holin protein analyzed by PSORTPrediction software ( Fig.12C in the figure). Using AlphaFold to predict the oligomeric forms of Holin protein and C17 mutant, it was found that the perforin protein C17 mutation had a significant impact on the oligomeric structure ( Fig.12 D and E in ).

[0127] (8) Analysis of bacterial lysis ability by co-expression of perforin Holin and lysin

[0128] BL21-28a-Holin, BL21△DsbA-28a-Holin, BL21-28a-Lysin, BL21△DsbA-28a-Lysin, BL21-Holin-Lysin and BL21△DsbA-Holin-Lysin were inoculated and shaken to OD 600 =0.3-0.4, add IPTG to a final concentration of 1mmol / L, induce at 28℃, 200r / min, and measure OD every 1h 600 , and draw a growth curve. The results showed that when Lysin was expressed alone, the growth of bacteria was not inhibited, but when Holin and Lysin were co-expressed in wild-type bacteria, bacterial lysis was accelerated ( Fig.13 ), while there was no significant difference in bacterial growth when Holin and Lysin were co-expressed in the deletion strain and when Lysin was expressed alone, indicating that the expression of Holin protein can accelerate the lysis of bacteria by lysin.

[0129] In summary, it is shown that DsbA protein can induce the perforin protein Holin to form oligomers using its own C17, causing damage to the bacterial inner membrane, thereby leading to the release of phage lytic enzymes and accelerating the death of bacteria.

[0130] The embodiments described above are only descriptions of the preferred embodiments of the present invention, and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope determined by the claims of the present invention.

Claims

1. The application of DsbD gene in improving the anti-phage ability of Escherichia coli, characterized in that: The DsbD gene is knocked out.

2. A DsbD gene-deficient Escherichia coli with phage resistance, characterized in that: It was obtained by knocking out the DsbD gene of Escherichia coli using Red homologous recombination technology.

3. Use of the DsbD gene-deficient Escherichia coli according to claim 2 in industrial fermentation.

4. The use of DsbD gene in inhibiting phage lysis of Escherichia coli, characterized in that: By knocking out the DsbD gene of Escherichia coli, the ability of phage to lyse Escherichia coli was inhibited.